The Committee That Guides Your Annual Flu Shot Doesn't Exist Right Now

Every fall, Americans roll up their sleeves for flu shots. Most don't think twice about the regulatory machinery that makes that routine possible. That machinery is currently broken.

The CDC's Advisory Committee on Immunization Practices — known as ACIP — has guided federal vaccine recommendations for over 60 years. It tells doctors what to recommend, tells insurers what to cover, and tells government programs what to reimburse. It's boring, essential infrastructure. And right now, it's legally suspended.

How It Got Here

In June 2025, Health and Human Services Secretary Robert F. Kennedy Jr. remade ACIP's roster — fast, and without following the legally required process for selecting new members. A federal judge ruled in March 2026 that Kennedy's actions violated federal law and effectively suspended the reconstituted committee. The Trump administration has appealed that ruling.

That appeal hasn't resolved anything. The committee remains nonfunctional as of June 7, 2026.

The FDA has already reviewed and approved updated flu vaccine formulations for this coming season — that part worked normally. The vaccines exist. The problem is the next step: no ACIP means no official federal recommendation for who should get them, when, and which formulations to prioritize.

What This Actually Means for Regular People

ACIP recommendations determine insurance coverage. Private insurers and government programs like Medicaid and Medicare use ACIP guidance to decide what they'll pay for. Without current recommendations, coverage for new flu vaccines this fall is in legal and administrative limbo.

Michelle Fiscus, a pediatrician and chief medical officer of the Association of Immunization Managers, told The Atlantic: "Even those of us who follow this 24/7 don't completely understand where anything stands right now."

Fiscus tracks vaccine policy for a living, yet the situation leaves her uncertain about the path forward.

The Administration Is Improvising

According to The Atlantic, Kennedy has made multiple attempts to issue a new ACIP charter since the court ruling — a necessary step toward reconstituting the panel legally. President Trump also signed an executive order in late May calling on CDC and ACIP to review a pared-down vaccination schedule the administration had previously assembled — the same schedule the judge's order voided.

Two options are reportedly on the table, according to Dorit Reiss, a vaccine-law expert at UC Law San Francisco. The administration could try to reconstitute a new, legally compliant ACIP in the coming months. Or acting CDC Director Jay Bhattacharya could simply issue recommendations himself, skipping the committee step entirely.

Both paths carry legal risk. Skipping ACIP opens the door to immediate court challenge. Rushing a new committee together risks repeating the same procedural errors that got them here in the first place.

What Mainstream Coverage Is Getting Wrong

Left-leaning outlets are framing this primarily as an anti-vaccine story — RFK Jr. the conspiracy theorist wrecking vaccine infrastructure. That framing isn't wrong, but it's incomplete.

The core problem here isn't whether anyone questions vaccine safety. The core problem is procedural incompetence. Kennedy didn't just install skeptics on the panel. He did it illegally. He ignored the administrative requirements that have governed federal advisory committees for decades. A first-year federal lawyer could have flagged the problem. This is basic regulatory compliance that the administration failed.

That's a government management failure, full stop. No ideology required to identify it.

Right-leaning outlets have largely downplayed the story or framed the court ruling as judicial overreach. But the judge didn't invent a new rule. The administration broke an existing one. Accountability applies regardless of which party is in charge.

The Bigger Picture

The flu vaccine is not a controversial product. Hundreds of millions of doses have been administered. It reduces hospitalizations and deaths, particularly among the elderly, children, and immunocompromised Americans. Debating its existence is a waste of time.

What IS a legitimate debate: the composition of ACIP, the independence of advisory panels from political pressure, and whether the CDC has become too insulated from outside scrutiny. Those are real questions. Kennedy could have pursued legitimate reform through legitimate process.

He didn't. He cut corners. A judge caught it. And now the federal government is scrambling to figure out how to issue routine vaccine guidance for the fall — something it has done without drama for six straight decades.

Nearly a dozen former ACIP members, former HHS officials, pediatricians, and vaccine lawyers told The Atlantic they have never seen this level of ambiguity around basic federal vaccine administration. Never. In 60-plus years.

What Comes Next

Vaccine manufacturers have done their job. The FDA has done its job. The only thing standing between Americans and a normal flu shot season is a self-inflicted bureaucratic catastrophe at HHS.

If the administration wants to reform vaccine advisory panels, it needs to do so legally and carefully — in a way that survives court challenge. The flu doesn't wait for appeals court schedules.

For now, basic questions remain unanswered: Will insurance cover the flu shot this fall? Which formulations will get federal backing? The federal government cannot provide a straight answer. That is a significant problem heading into the 2026 flu season.